T2 Biosystems, Inc.
TTOO · OTC
9/30/2024 | 6/30/2024 | 3/31/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $2 | $4 | $6 | $16 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $2 | $1 | $2 | $1 |
| Inventory | $4 | $5 | $5 | $5 |
| Other Curr. Assets | $2 | $2 | $3 | -$0 |
| Total Curr. Assets | $10 | $13 | $16 | $25 |
| Property Plant & Equip (Net) | $8 | $8 | $9 | $9 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $1 | $1 | $1 | $1 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | -$0 | -$0 | $0 |
| Total NC Assets | $8 | $9 | $9 | $10 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $18 | $22 | $25 | $35 |
| Liabilities | – | – | – | – |
| Payables | $4 | $2 | $2 | $2 |
| Short-Term Debt | $12 | $12 | $42 | $41 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $3 | $4 | $9 | $9 |
| Total Curr. Liab. | $24 | $22 | $56 | $56 |
| LT Debt | $0 | $0 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $5 | $6 | $6 | $7 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $7 | $7 | $6 | $7 |
| Total Liabilities | $30 | $28 | $63 | $63 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$617 | -$607 | -$598 | -$584 |
| AOCI | $0 | $0 | $0 | $0 |
| Other Equity | $0 | $0 | $0 | $0 |
| Total Equity | -$12 | -$6 | -$38 | -$28 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $18 | $22 | $25 | $35 |
| Net Debt | $10 | $8 | $35 | $26 |